Elevai Labs Inc (NASDAQ:ELAB) does about 123.29M shares in volume on a normal day but saw 302156625 shares change hands in the recent trading day. The company now has a market cap of 8.19M USD. Its current market price is $0.02, marking a decrease of -20.90% compared to the previous close of $0.02. The 52 week high reached by this stock is $4.24 whilst the lowest price level in 52 weeks is $0.02.
Elevai Labs Inc (ELAB) has a 20-day trading average at $0.0305 and the current price is -99.63% off the 52-week high compared with -1.24% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.0868 and its 200-day simple moving average is $0.4485. If we look at the stock’s price movements over the week, volatility stands at 11.86%, which increases to 22.80% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 25.05 to suggest the stock is oversold.
The current price level is -47.85%, -81.68%, and -96.46% away from its SMA20, SMA50, and SMA200 respectively, with the ELAB price moving above the 50-day SMA on current market day. Elevai Labs Inc (ELAB) stock is down -30.57% over the week and -84.30% over the past month. Its price is -99.13% year-to-date and -99.57% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
Outstanding shares total 49.38M with insiders holding 72.98% of the shares and institutional holders owning 18.20% of the company’s common stock. The company has a return on investment of -63.92% and return on equity of -130.35%. The beta has a value of -1.00. Price to book ratio is 0.09 and price to sales ratio is 3.34.
